The vaccine is indicated for use in infants and children 6 weeks through 5 years of age (before the 6th birthday).
The vaccine elicits immune responses in recipients following immunization, and is indicated for the prevention of invasive disease caused by 13 serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) of Streptococcus pneumoniae.
The vaccine does not protect against diseases caused by Streptococcus pneumoniae serotypes that are not contained in the vaccine.